BLP-1 is a bombinin-like peptide derived from the skin of frogs, primarily studied for its antimicrobial properties against bacteria and fungi, making it a potential candidate for developing new antibiotics. It has shown effectiveness against a range of bacteria, including drug-resistant strains, which is crucial in addressing the growing issue of antibiotic resistance. Additionally, BLP-1 is being explored for its role in immune system modulation, potentially aiding in the treatment of infections and inflammatory conditions. Research also suggests its application in wound healing, where its antimicrobial and anti-inflammatory effects could promote faster recovery. Further studies are investigating its potential use in medical coatings for implants to prevent bacterial colonization and infections.